Efavirenz Supplier-Buyer Network — Trade Flow Analysis

Name: Efavirenz Supplier-Buyer Trade Network Dataset — 101+ Indian Exporters, 19+ Importers, 121+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Efavirenz supplier network, Efavirenz buyers, pharmaceutical export India, Efavirenz trade data

TransData Nexus

Efavirenz

India Pharmaceutical Trade Intelligence

$60.2M101 Suppliers121 CountriesHS 30049099

ExportsIndia → SOUTH AFRICA49.2%India → BELARUS7.1%

ImportsBELGIUM → India$10.1K UNITED KINGDOM → India$8.5K

Who Supplies Efavirenz? Top Manufacturers & Buyers 2026 — MACLEODS PHARMACEUTICALS LTD Leads | TransData Nexus | TransData Nexus

1MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the first-largest Efavirenz exporter from India, with a market share of 29.6% and a total export value of $17.8M across 121 shipments. Their average shipment value of $147.1K is above the market average of $55.5K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. MACLEODS PHARMACEUTICALS SA (PTY) is the dominant customer, accounting for 63.3% of this supplier's tracked business. Top customers include:

• MACLEODS PHARMACEUTICALS SA (PTY) — $11.3M across 77 shipments (63.3% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS S R O — $3.6M across 25 shipments (20.3% of this supplier's total exports)

• ICU VITA — $2.1M across 14 shipments (11.6% of this supplier's total exports)

• NATIONAL CENTER FOR DISEASE CONTROL — $517.8K across 4 shipments (2.9% of this supplier's total exports)

• SYNOPTIS INDUSTRIAL SP .ZO.O — $342.4K across 2 shipments (1.9% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $147.1K is 165% above the market average of $55.5K, consistent with large-order contracts or value-added formulations.

2MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the second-largest Efavirenz exporter from India, with a market share of 28.0% and a total export value of $16.9M across 167 shipments. Their average shipment value of $101.0K is above the market average of $55.5K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. VIATRIS HEALTHCARE (PTY) LTD, is the dominant customer, accounting for 80.7% of this supplier's tracked business. Top customers include:

• VIATRIS HEALTHCARE (PTY) LTD, — $13.6M across 135 shipments (80.7% of this supplier's total exports)

• PAHANG PHARMACY SDN BHD — $1.2M across 12 shipments (7.0% of this supplier's total exports)

• PAHANG PHARMACY SDN BHD — $1.1M across 11 shipments (6.6% of this supplier's total exports)

• VIATRIS HEALTHCARE PTY LIMITED — $702.8K across 7 shipments (4.2% of this supplier's total exports)

• CENTRAL MEDICAL STOR — $265.0K across 3 shipments (1.6% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $101.0K is 82% above the market average of $55.5K, consistent with large-order contracts or value-added formulations.

3CIPLA LIMITED

CIPLA LIMITED is the third-largest Efavirenz exporter from India, with a market share of 7.8% and a total export value of $4.7M across 59 shipments. Their average shipment value of $79.2K is above the market average of $55.5K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. STATE ENTERPRISE ACADEMPHARM is the dominant customer, accounting for 84.7% of this supplier's tracked business. Top customers include:

• STATE ENTERPRISE ACADEMPHARM — $4.0M across 50 shipments (84.7% of this supplier's total exports)

• CIPLA COLOMBIA SAS Y/O DEPOSITO UPS — $246.0K across 3 shipments (5.3% of this supplier's total exports)

• PHARMACIE CENTRALE D — $173.7K across 2 shipments (3.7% of this supplier's total exports)

• PHARMACIE CENTRALE D — $147.1K across 2 shipments (3.1% of this supplier's total exports)

• CIPLA COLOMBIA SAS Y/O DEPOSITO UPS — $145.7K across 2 shipments (3.1% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $79.2K is 43% above the market average of $55.5K, consistent with large-order contracts or value-added formulations.

4MACLEODS PHARMACEUTICALS LIMITED

MACLEODS PHARMACEUTICALS LIMITED is the fourth-largest Efavirenz exporter from India, with a market share of 3.9% and a total export value of $2.3M across 56 shipments. Their average shipment value of $41.9K is below the market average of $55.5K, reflecting a high-volume, competitive pricing strategy.

MACLEODS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• NATIONAL EMERGENCY RESPONSE COUNCIL HIV — $1.0M across 25 shipments (44.3% of this supplier's total exports)

• MACLEODS PHARMACEUTICALS SA (PTY) — $601.0K across 14 shipments (25.6% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS S R O — $390.3K across 9 shipments (16.6% of this supplier's total exports)

• ALSTONS MARKETING CO — $166.7K across 4 shipments (7.1% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS S R O — $150.7K across 4 shipments (6.4% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LIMITED operates with high shipment frequency (56 shipments) at a per-shipment value of $41.9K, indicating a broad distribution network with many smaller, regular orders.

5HETERO LABS LIMITED

HETERO LABS LIMITED is the fifth-largest Efavirenz exporter from India, with a market share of 1.7% and a total export value of $1.0M across 49 shipments. Their average shipment value of $21.4K is below the market average of $55.5K, reflecting a high-volume, competitive pricing strategy.

HETERO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER OF — $324.2K across 15 shipments (30.9% of this supplier's total exports)

• M S TO THE ORDER OF — $212.2K across 10 shipments (20.2% of this supplier's total exports)

• XXN AXXRICXX HEXXTH — $203.7K across 10 shipments (19.4% of this supplier's total exports)

• XXN AXXRICXX HEXXTH — $203.5K across 10 shipments (19.4% of this supplier's total exports)

• TO THE ORDER — $105.5K across 5 shipments (10.1% of this supplier's total exports)

Key Insight: HETERO LABS LIMITED operates with high shipment frequency (49 shipments) at a per-shipment value of $21.4K, indicating a broad distribution network with many smaller, regular orders.

6MICRO LABS LIMITED

MICRO LABS LIMITED is the fifth-largest Efavirenz exporter from India, with a market share of 1.4% and a total export value of $849.5K across 55 shipments. Their average shipment value of $15.4K is below the market average of $55.5K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DIGECITSS-MINISTERIO DE SALUD — $260.0K across 17 shipments (30.6% of this supplier's total exports)

• UNOPS MYANMAR OC — $230.2K across 15 shipments (27.1% of this supplier's total exports)

• ETHIOPIAN PHARMACEUT — $171.6K across 11 shipments (20.2% of this supplier's total exports)

• UNOPS MYANMAR OC — $101.6K across 7 shipments (12.0% of this supplier's total exports)

• RWANDA MEDICAL SUPPL — $86.2K across 6 shipments (10.1% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (55 shipments) at a per-shipment value of $15.4K, indicating a broad distribution network with many smaller, regular orders.

1South Africa

South Africa ranks as the first-largest destination for Efavirenz imports from India, with a total trade value of $29.6M across 41 shipments — representing a 49.2% share of all Efavirenz exports. The average shipment value of $721.8K is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Efavirenz importers in South Africa: VIATRIS HEALTHCARE (PTY) LTD, is the largest buyer, accounting for 47.8% ($14.1M) of this market's total imports.

• VIATRIS HEALTHCARE (PTY) LTD, — $14.1M (47.8% of South Africa's total)

• MACLEODS PHARMACEUTICALS SA — $12.2M (41.4% of South Africa's total)

• NATIONAL EMERGENCY RESPONSE COUNCIL HIV — $1.0M (3.5% of South Africa's total)

Key Insight: South Africa's per-shipment average of $721.8K (1200% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Efavirenz imports from India.

Primary Market

Secondary Market

2Belarus

Belarus ranks as the second-largest destination for Efavirenz imports from India, with a total trade value of $4.3M across 3 shipments — representing a 7.1% share of all Efavirenz exports. The average shipment value of $1.4M is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Efavirenz importers in Belarus: STATE ENTERPRISE ACADEMPHARM is the largest buyer, accounting for 92.4% ($4.0M) of this market's total imports.

• STATE ENTERPRISE ACADEMPHARM — $4.0M (92.4% of Belarus's total)

Key Insight: Belarus's per-shipment average of $1.4M (2471% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belarus is a key market for Efavirenz imports from India.

Primary Market

Secondary Market

3United Kingdom

United Kingdom ranks as the third-largest destination for Efavirenz imports from India, with a total trade value of $4.2M across 4 shipments — representing a 6.9% share of all Efavirenz exports. The average shipment value of $1.0M is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Efavirenz importers in United Kingdom: GLENMARK PHARMACEUTICALS EUROPE LTD is the largest buyer, accounting for 86.4% ($3.6M) of this market's total imports.

• GLENMARK PHARMACEUTICALS EUROPE LTD — $3.6M (86.4% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $1.0M (1781% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Efavirenz imports from India.

Primary Market

Secondary Market

4Malaysia

Malaysia ranks as the fourth-largest destination for Efavirenz imports from India, with a total trade value of $3.5M across 57 shipments — representing a 5.8% share of all Efavirenz exports. The average shipment value of $61.3K is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Efavirenz importers in Malaysia: PAHANG PHARMACY SDN BHD, is the largest buyer, accounting for 47.8% ($1.7M) of this market's total imports.

• PAHANG PHARMACY SDN BHD, — $1.7M (47.8% of Malaysia's total)

• PAHANG PHARMACY SDN BHD — $1.4M (41.4% of Malaysia's total)

Key Insight: Malaysia's per-shipment average of $61.3K (10% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Malaysia is a key market for Efavirenz imports from India.

Primary Market

Secondary Market

5Uruguay

Uruguay ranks as the fifth-largest destination for Efavirenz imports from India, with a total trade value of $2.1M across 2 shipments — representing a 3.5% share of all Efavirenz exports. The average shipment value of $1.0M is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Efavirenz importers in Uruguay: ICU VITA is the largest buyer, accounting for 99.8% ($2.1M) of this market's total imports.

• ICU VITA — $2.1M (99.8% of Uruguay's total)

Key Insight: Uruguay's per-shipment average of $1.0M (1771% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Uruguay is a key market for Efavirenz imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Efavirenz.
2.Flow Mapping: 101 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,084 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 121 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,084 Verified Shipments

101 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Efavirenz

Efavirenz

Who Supplies Efavirenz? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Efavirenz? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Efavirenz Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MACLEODS PHARMACEUTICALS LTD

2MYLAN LABORATORIES LIMITED

3CIPLA LIMITED

4MACLEODS PHARMACEUTICALS LIMITED

5HETERO LABS LIMITED

6MICRO LABS LIMITED

From Indian Factories to Global Pharmacies — How Efavirenz Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Efavirenz Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1South Africa

2Belarus

3United Kingdom

4Malaysia

5Uruguay

People Also Ask — Efavirenz Supplier & Trade Network

Efavirenz Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology